Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,211 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07498270Recruiting
Brain stimulation during sleep for healthy adults
This study tests a new type of gentle brain stimulation during sleep to see how it affects brain activity. If you are a healthy adult without certain medical conditions, you may help researchers understand how this stimulation works.
Madison, WisconsinAges 18–40 - NCT07511205RecruitingPhase 1
Study of AZD1043 for overweight or obesity
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
Glendale, CaliforniaAges 18–65 - NCT07527923RecruitingPhase 1
Testing REGN20423 for healthy people and atopic dermatitis
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
Leuven, Vlaams-BrabantAges 18–65 - NCT07554365RecruitingPhase 1
Safety Study of AN01 Inhaled Powder in Healthy Adults
This early-stage trial tests whether AN01, a new inhaled powder medication, is safe and well-tolerated in healthy people. Researchers will measure how the body processes the drug and watch for any side effects.
Adelaide, South AustraliaAges 18–60 - NCT07570992RecruitingPhase 1
Safety study of NNC1679-0001 in healthy people and people with type 2 diabetes
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
GrazAges 18–64 - NCT07580924RecruitingPhase 1
Safety Study of NHL907 in Healthy Adults
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
Adelaide, South AustraliaAges 18–60 - NCT07588139RecruitingPhase 1
Testing two JAK inhibitor medicines in healthy adults
This early-stage study tests how two experimental medicines (povorcitinib by mouth and ruxolitinib cream on skin) work in healthy volunteers. Researchers will measure how these drugs move through your body and affect your skin to learn if they're safe and effective.
Dilworth, MinnesotaAges 18–65 - NCT07635095RecruitingPhase 1
Comparing two forms of navenibart in healthy adults
This study tests whether two different presentations (forms) of an experimental medicine called navenibart work the same way in your body. Researchers will measure how the drug moves through your system to ensure both forms are safe and effective.
Daytona Beach, FloridaAges 18–55 - NCT07640438RecruitingPhase 1
Safety Study of New Drug in Healthy Adults
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hangzhou, ZhejiangAges 18 years+ - NCT07641881RecruitingPhase 1
Testing a New Tablet's Absorption and Food Effects
This study tests how well the body absorbs a new experimental drug (casdatifan) in tablet form, and whether eating food changes how it works. Researchers will compare two tablet strengths and measure absorption in healthy adults.
Tempe, ArizonaAges 18–55 - NCT07108946Enrolling by invitation
Ear scanning study: color and skin tone effects
This study tests how different background colors and skin tones affect the accuracy of scanning ears. It may help improve scanning technology for people with various skin types.
Cairo, AbbasyaAges Any age - NCT07079124Enrolling by invitation
Social program for older adults in nursing homes
This study tests a social participation program designed to help older adults who live in nursing homes stay connected and engaged. It may help you feel more active and involved in your community.
Fuzhou, FujianAges 60 years+ - NCT06867107Enrolling by invitationPhase 2
Long-term follow-up study of SAT-3247 for Duchenne
This is a long-term follow-up study for people with Duchenne muscular dystrophy who already took part in a previous SAT-3247 trial. It checks how safe and effective the treatment stays over a longer time.
Melbourne, VictoriaAges 18–40 - NCT05632120Enrolling by invitation
Testing how COPD affects daily movement and participation
This study looks at how chronic obstructive pulmonary disease (COPD) may affect your body function, walking, and ability to take part in everyday life. It may help researchers understand what support or therapies could improve daily activities.
Istanbul, Fatih/İstanbulAges 35–80 - NCT07759791Recruiting
Life coaching after stroke to rejoin valued activities
This trial tests a coaching program that helps people who have had a stroke get back into activities they value, like hobbies or social outings. It may help you feel more connected and improve your quality of life.
Kingston, OntarioAges 18 years+ - NCT07416123RecruitingPhase 1
Study of a new drug for advanced solid tumors
This trial tests an experimental drug, GEN1106, for people with solid tumors that have not responded to standard treatments. It aims to see if the drug can help shrink or control the cancer.
New Haven, ConnecticutAges 18 years+ - NCT06797336RecruitingPhase 1
Study of PT0253 for advanced KRAS G12D mutated tumors
This trial tests an experimental drug called PT0253 for people with advanced or metastatic cancers that have a specific genetic change called KRAS G12D. The drug may help shrink or slow the growth of these tumors, and the study will also check for side effects.
Los Angeles, CaliforniaAges 18 years+ - NCT07675811RecruitingPhase 3
Study of a new treatment for cat allergy related eye symptoms
This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.
Andover, MassachusettsAges 8 years+ - NCT07563881RecruitingPhase 3
Testing RAP-219 for Focal Seizure Control in Adults
This study tests whether a new medication called RAP-219 can help adults with focal seizures (seizures that start in one area of the brain) control their seizures better. You would take this medication alongside your current seizure drugs for about 12 weeks.
Palmdale, CaliforniaAges 18–75 - NCT06801834RecruitingPhase 3
Study of sacituzumab govitecan vs. standard care for advanced small cell lung cancer
This trial tests a new drug called sacituzumab govitecan against the usual treatments for people with extensive-stage small cell lung cancer that has gotten worse after initial chemotherapy. It aims to see if the new drug helps patients live longer or have better outcomes.
Anchorage, AlaskaAges 18 years+ - NCT07018323RecruitingPhase 2
Study of IMVT-1402 for Graves' disease
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
Tucson, ArizonaAges 18–75 - NCT07159841RecruitingPhase 2/Phase 3
Study of a new drug for children with classic CAH
This study tests a new medication for children with classic congenital adrenal hyperplasia (CAH). It aims to see if the drug helps better control hormone levels and reduce the need for high doses of current steroid medicines.
San Francisco, CaliforniaAges 1–17 - NCT06303193RecruitingPhase 1/Phase 2
Testing a kinase inhibitor drug for MDS and MDS/MPN in adults and teens
This trial tests a drug called pacritinib in people with myelodysplastic syndromes (MDS) or MDS/myeloproliferative neoplasms (MDS/MPN). The drug targets several proteins that may help control the disease, especially for those who have not responded to other treatments.
Bethesda, MarylandAges 12–120 - NCT07675135RecruitingPhase 3
Testing a new narcolepsy drug for excessive daytime sleepiness
This study tests a new medicine, HBS-301, for people with narcolepsy type 1 or type 2 who still have excessive daytime sleepiness. If you take other medications for sleepiness or mood, they must be stable for at least 3 months, and you cannot take some as-needed sleepiness medicines.
Birmingham, AlabamaAges 18 years+
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,211 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.